Pharmaceutical & Biopharma M&A
Expert capital advisory solutions for pharmaceutical and drug companies.
How we work
Mergers & Acquisitions
We specialize in strategic mergers, acquisitions, restructurings, divestitures, and business combinations on both the buy and sell side. Our services are designed to help clients navigate complex transactions, maximize value, and achieve long-term growth objectives.
Private Placements
We offer a range of private investment services, including Private Investments in Public Equity (PIPEs), Initial Public Offerings (IPOs), and Registered Direct Offerings (RDOs). These options provide clients with strategic pathways to raise capital and access public markets efficiently.
Product Partnerships
Licensing and partnership arrangements offer a strategic way to access growth resources without requiring equity dilution or the sale of ownership by existing shareholders. These agreements can also generate substantial capital to support further business expansion.
Our M&A Process
Strategic Planning
Define the company’s long-term vision and determine how mergers or acquisitions align with overall business goals.This step sets the foundation for identifying the right type of transaction and desired outcomes.
Assess Financial Readiness
Evaluate current financial health, cash flow, and capital structure to determine the ability to support a deal. This may involve internal audits, valuation analysis, and preparing financial documentation for transparency.
Research Target Industry
Analyze market dynamics, competition, regulatory environment, and emerging trends within the target sector.This research helps to identify risks and growth opportunities that could impact the deal’s success.
Target List Building
Develop a focused list of high-potential acquisition targets or prospective buyers based on strategic fit.The list is often prioritized based on financial performance, market position, and synergy potential.
Target Outreach
Initiate confidential contact with selected targets to assess interest and explore potential deal scenarios.Initial communication is typically discreet and may involve intermediaries to protect confidentiality.
Engage Targets
Begin meaningful conversations to evaluate strategic alignment, cultural compatibility, and mutual goals.This stage helps determine whether to proceed to more formal negotiations.
Letter of Intent (LOI)
Draft a non-binding agreement that outlines the basic terms, structure, and timeline of the potential deal.The LOI signals serious interest and sets the stage for due diligence.
Due Diligence
Conduct a comprehensive investigation into the target's financials, operations, legal matters, and risks.This step is critical to validating deal assumptions and avoiding post-transaction surprises.
Closing
Execute final agreements, obtain necessary approvals, and complete the legal and financial components of the deal.This includes signing of contracts, transfer of funds, and formal deal announcements.
Target Integration
Align systems, processes, teams, and cultures to ensure smooth operational and strategic integration post-deal.Successful integration maximizes value creation and helps realize synergies from the transaction.
Results + Impact
75%
Increase in operational efficiency
$5M+
Cost savings achieved
90%
Client retention rate
100+
Projects successfully completed
Pharmaceuticals Investment Bank
Our firm provides specialized capital advisory and investment banking solutions to pharmaceutical and biotechnology companies within the middle market. We work across a variety of key sectors including over-the-counter products, drug discovery and development, generics, biosimilars, nutraceuticals, medical technology, and agricultural biotechnology.

With deep regulatory knowledge and an extensive network of experienced dealmakers, we guide clients through complex transactions such as growth financing and M&A, ensuring full value is realized throughout the value chain. Every engagement is customized to meet the specific short- and long-term objectives of each client, recognizing that no two deals are exactly alike. This tailored approach, combined with strategic insight and sector expertise, positions us as a trusted advisor in the pharmaceutical and biotech space.
How we work